News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
392,010 Results
Type
Article (18377)
Company Profile (120)
Press Release (373513)
Multimedia
Podcasts (37)
Webinars (9)
Section
Business (119458)
Career Advice (982)
Deals (19724)
Drug Delivery (33)
Drug Development (33064)
Employer Resources (68)
FDA (9322)
Job Trends (8409)
News (183994)
Policy (13562)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (6)
2024 BioMidwest Digital (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (10)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (1)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (1)
2025 Lone Star Bio Digital (3)
2026 BioCapital Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Genetown Elite (1)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (1546)
Accelerated approval (3)
Adcomms (1)
Allergies (43)
Alliances (36403)
ALS (28)
Alzheimer's disease (563)
Antibody-drug conjugate (ADC) (70)
Approvals (9351)
Artificial intelligence (249)
Autoimmune disease (5)
Automation (14)
Bankruptcy (146)
Best Places to Work (6970)
BIOSECURE Act (7)
Biosimilars (11)
Biotechnology (88)
Bladder cancer (23)
Brain cancer (14)
Breast cancer (125)
Cancer (1081)
Cardiovascular disease (68)
Career advice (826)
Career pathing (17)
CAR-T (107)
Cell therapy (274)
Cervical cancer (10)
Clinical research (25925)
Collaboration (633)
Compensation (113)
Complete response letters (4)
COVID-19 (1261)
CRISPR (40)
C-suite (151)
Cystic fibrosis (50)
Data (1009)
Decentralized trials (1)
Denatured (18)
Depression (18)
Diabetes (107)
Diagnostics (5155)
Digital health (17)
Diversity (4)
Diversity, equity & inclusion (17)
Drug discovery (81)
Drug pricing (13)
Drug shortages (7)
Duchenne muscular dystrophy (24)
Earnings (40587)
Editorial (4)
Employer branding (9)
Employer resources (61)
Events (54689)
Executive appointments (446)
FDA (9996)
Featured Employer (29)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (497)
Gene editing (89)
Generative AI (25)
Gene therapy (175)
GLP-1 (246)
Government (1429)
Grass and pollen (2)
Guidances (28)
Healthcare (10782)
Huntington's disease (6)
IgA nephropathy (11)
Immunology and inflammation (34)
Indications (12)
Infectious disease (1344)
Inflammatory bowel disease (67)
Inflation Reduction Act (3)
Influenza (36)
Intellectual property (63)
Interviews (197)
IPO (8431)
IRA (8)
Job creations (1728)
Job search strategy (699)
Kidney cancer (4)
Labor market (11)
Layoffs (142)
Leadership (7)
Legal (2781)
Liver cancer (36)
Lung cancer (135)
Lymphoma (66)
Machine learning (3)
Management (23)
Manufacturing (197)
MASH (18)
Medical device (11922)
Medtech (11927)
Mergers & acquisitions (11641)
Metabolic disorders (225)
Multiple sclerosis (28)
NASH (4)
Neurodegenerative disease (35)
Neuropsychiatric disorders (4)
Neuroscience (767)
NextGen: Class of 2025 (3917)
Non-profit (1802)
Northern California (1147)
Now hiring (15)
Obesity (95)
Opinion (95)
Ovarian cancer (40)
Pain (48)
Pancreatic cancer (51)
Parkinson's disease (68)
Partnered (13)
Patents (153)
Patient recruitment (58)
Peanut (28)
People (35240)
Pharmaceutical (19)
Pharmacy benefit managers (1)
Phase I (9481)
Phase II (11674)
Phase III (7638)
Pipeline (573)
Policy (31)
Postmarket research (570)
Preclinical (4318)
Press Release (68)
Prostate cancer (42)
Psychedelics (4)
Radiopharmaceuticals (166)
Rare diseases (138)
Real estate (3839)
Recruiting (27)
Regulatory (10198)
Reports (19)
Research institute (1443)
Resumes & cover letters (150)
Rett syndrome (3)
RNA editing (2)
RSV (25)
Schizophrenia (14)
Series A (93)
Series B (52)
Service/supplier (7)
Sickle cell disease (18)
Southern California (1218)
Special edition (2)
Spinal muscular atrophy (59)
Sponsored (18)
Startups (2660)
State (2)
Stomach cancer (2)
Supply chain (30)
Tariffs (2)
The Weekly (18)
United States (12004)
Vaccines (338)
Venture capitalists (20)
Weight loss (43)
Women's health (17)
Worklife (4)
Date
Today (100)
Last 7 days (297)
Last 30 days (1285)
Last 365 days (18205)
2025 (5300)
2024 (19747)
2023 (23255)
2022 (32526)
2021 (34398)
2020 (32609)
2019 (27893)
2018 (21044)
2017 (20227)
2016 (19084)
2015 (21966)
2014 (16465)
2013 (14001)
2012 (15122)
2011 (15536)
2010 (13954)
Location
Africa (403)
Alabama (41)
Alaska (6)
Arizona (126)
Arkansas (10)
Asia (25871)
Australia (4444)
California (3001)
Canada (1065)
China (259)
Colorado (168)
Connecticut (131)
Delaware (46)
Europe (52936)
Florida (518)
Georgia (137)
Idaho (33)
Illinois (297)
India (13)
Indiana (172)
Iowa (5)
Japan (110)
Kansas (85)
Kentucky (7)
Louisiana (8)
Maine (44)
Maryland (472)
Massachusetts (2089)
Michigan (193)
Minnesota (266)
Mississippi (2)
Missouri (63)
Montana (24)
Nebraska (15)
Nevada (24)
New Hampshire (66)
New Jersey (926)
New Mexico (19)
New York (896)
North Carolina (554)
North Dakota (7)
Northern California (1147)
Ohio (113)
Oklahoma (11)
Oregon (20)
Pennsylvania (610)
Puerto Rico (9)
Rhode Island (25)
South America (589)
South Carolina (20)
South Dakota (1)
Southern California (1218)
Tennessee (67)
Texas (475)
Utah (108)
Virginia (61)
Washington D.C. (16)
Washington State (346)
West Virginia (3)
Wisconsin (37)
392,010 Results for "kvk tech".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
KVK Tech’s Lomaira has successfully completed registration in Mexico through its partner Medix
August 1, 2024
·
4 min read
Policy
KVK-Tech, Inc. Issues Voluntary Nationwide Recall of one lot of Betaxolol Tablets, USP 10 mg (Batch Number: 17853A) as a precautionary measure due to a single foreign tablet found during the line clearance after the batch was packaged
KVK-Tech, Inc. is voluntarily recalling one lot of Betaxolol Tablets, USP 10 mg, White, Round, film coated biconvex tablets, debossed “K” above bisect “13" on one side and plain on the other side” to the consumer level.
September 29, 2023
·
3 min read
Press Releases
Addgene Adds Science and Tech Leaders to Its Management Team and Board of Directors
April 16, 2025
·
5 min read
Drug Development
Trust, Tech, and Tomorrow: A Pharmaceutical Executive’s WEF Insights
Konstantina Katcheves, Senior VP of Innovative Global Business Development at Teva Pharmaceuticals brings insights from the World Economic Forum to SCOPE 2025.
March 5, 2025
·
1 min read
·
Lori Ellis
Business
KVK Tech Announces Phase II Trial of COVID-19 Oral Therapy is Currently Enrolling in Nepal
Sen-Jam Pharmaceuticals and KVK Tech are collaborating to develop a Covid-19 oral therapy.
May 5, 2022
·
2 min read
Press Releases
Turing Medical Names Transformative Med Tech Leader Kevin King as President and Chief Executive Officer
April 15, 2025
·
2 min read
Pharm Country
Sen-Jam Pharmaceutical Partners with Specialty Pharmaceutical Manufacturer to Provide Formulation and Chemistry, Manufacturing & Controls for Revolutionary Anti-Inflammatory Injectable
Sen-Jam Pharmaceutical, an innovative life sciences company developing a portfolio of revolutionary anti-inflammatories by repurposing existing molecules for novel uses, has entered a third strategic partnership with KVK-Tech.
April 10, 2024
·
4 min read
Press Releases
EssilorLuxottica acquires the Canadian med-tech start-up Cellview
February 11, 2025
·
1 min read
Press Releases
Fangzhou Inc.'s H2H Smart Healthcare Platform Honored as one of Guangdong’s Premier High-Tech Innovation Products
March 17, 2025
·
2 min read
Business
UFC and Aires Tech Announce Multi-Year Global Marketing Partnership
UFC®, the world’s premier mixed martial arts organization, and American Aires Inc. (CSE: WIFI) (OTCQB: AAIRF) (Aires Tech or Aires), a pioneer in cutting-edge technology designed to protect against electromagnetic radiation and optimize human health, today announced a new global marketing partnership that will showcase Aires Tech branding within UFC’s biggest events.
May 30, 2024
·
9 min read
1 of 39,201
Next
